If you're thinking about joining Caduceus as a Limited Partner, you may have seen the term “accredited investor.” It's not just a buzzword — it’s a legal requirement that determines who can invest in private funds like ours.
Let’s explain what it means, why it exists, and how it applies to you.
What Is an Accredited Investor?
An accredited investor is someone who meets specific financial or professional qualifications set by the U.S. Securities and Exchange Commission (SEC). You qualify if you meet just one of these:
-
Earn at least $200,000 per year ($300,000 with a spouse) for the past two years
-
Have a net worth over $1 million, not including your home
-
Hold certain financial licenses or work in a qualifying investment role
Why Does the SEC Require This?
Private investment opportunities — like the ones offered by Caduceus — are not registered or traded publicly like stocks. That means they don’t go through the same disclosure process. They’re considered higher risk.
The SEC uses accreditation to make sure these investments are only available to individuals who:
-
Understand the risks
-
Can afford potential losses
-
Likely have access to professional advice
It’s about protecting investors, not limiting access for its own sake.
How Does This Affect You at Caduceus?
Caduceus operates under a legal structure known as a private placement. To comply with U.S. securities laws, we are only allowed to show deals to accredited investors.
That’s why we ask every new member to complete a short Accredited Investor Questionnaire. It’s not just a formality — it’s a required part of the onboarding process.
Once your status is verified, you’ll be able to:
-
Join our investor network
-
Access live and upcoming deal opportunities
-
Attend webinars and learning sessions
-
Connect with other physician investors
Why This Makes Sense for You
Being an accredited investor doesn’t just check a legal box — it gives you access to investments the general public can’t see. At Caduceus, our deals are sourced through physician networks, scientific review, and strategic diligence. You’re not just investing in startups — you’re investing in innovation that matters to medicine.
We want our LPs to understand what they’re investing in and why — and we believe our model empowers doctors to do just that.